ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $150,000 | +188.5% | 105,410 | +368.2% | 0.00% | – |
| Q3 2017 | $52,000 | +136.4% | 22,512 | +37.7% | 0.00% | – |
| Q2 2017 | $22,000 | -86.7% | 16,352 | -56.5% | 0.00% | – |
| Q4 2016 | $166,000 | -89.3% | 37,621 | -88.3% | 0.00% | -100.0% |
| Q3 2016 | $1,556,000 | +233.2% | 320,806 | +126.8% | 0.00% | +200.0% |
| Q2 2016 | $467,000 | -64.9% | 141,461 | -62.3% | 0.00% | -50.0% |
| Q1 2016 | $1,332,000 | – | 375,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
| SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
| Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
| Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
| ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
| Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
| NWAM LLC | 20,000 | $30,000 | 0.01% |